Gene discovery using the serial analysis of gene expression technique: Implications for cancer research

Journal of Clinical Oncology

Volumn 19, Issue 11, 2001, Pages 2948-2958

  Polyak, K ^a   Riggins, G J ^a  

^a DANA FARBER CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; COMPLEMENTARY DNA; MESSENGER RNA; OLIGONUCLEOTIDE;

ARTICLE; CANCER CELL; CANCER RESEARCH; CANCER THERAPY; CARCINOGENESIS; CELL POPULATION; DIAGNOSTIC ACCURACY; DNA LIBRARY; DNA MICROARRAY; GENE EXPRESSION; GENE MUTATION; GENE TARGETING; GENETIC ANALYSIS; HUMAN; HUMAN CELL; ONCOGENE C MYC; PHENOTYPE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGNOSIS; QUANTITATIVE DIAGNOSIS; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR GENE;

EID: 0035367507     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2001.19.11.2948     Document Type: Article

References (74)

1. Serial analysis of gene expression
2. Accessing genetic information with high-density DNA arrays
3. The sequence of the human genome
4. Direct comparison of GeneChip and SAGE on the quantitative accuracy in transcript profiling analysis
5. Analysis of human transcriptomes
6. Enhanced concatemer cloning: A modification to the SAGE (Serial Analysis of Gene Expression) technique
7. Substantially enhanced cloning efficiency of SAGE (Serial Analysis of Gene Expression) by adding a heating step to the original protocol
8. Improved NlaIII digestion of PAGE-purified 102 bp ditags by addition of a single purification step in both the SAGE and microSAGE protocols
9. MicroSAGE: A modified procedure for serial analysis of gene expression in limited amounts of tissue
10. Serial microanalysis of renal transcriptomes
11. Comprehensive transcript analysis in small quantities of mRNA by SAGE-lite
12. Molecular phenotype of the human oocyte by PCR-SAGE
13. Serial analysis of gene expression to assess the endothelial cell response to an atherogenic stimulus
14. Characterization of gene expression in resting and activated mast cells
15. Serial analysis of gene expression in human monocyte-derived dendritic cells
16. Serial analysis of gene expression in human monocytes and macrophages
17. Identification of genes specifically expressed in human activated and mature dendritic cells through serial analysis of gene expression
18. Comprehensive gene expression profile of LPS-stimulated human monocytes by SAGE
19. Identification of diverse nerve growth factor-regulated genes by serial analysis of gene expression (SAGE) profiling
20. Comprehensive gene expression profile of a normal human liver
21. A public database for gene expression in human cancers
22. SAGEmap: A public gene expression resource
23. Gene expression profiles in normal and cancer cells
24. Serial analysis of gene expression in non-small cell lung cancer
25. Combining serial analysis of gene expression and array technologies to identify genes differentially expressed in breast cancer
26. Reduced expression of PSCA, a member of the LY-6 family of cell surface antigens, in bladder, esophagus, and stomach tumors
27. Identifying potential tumor markers and antigens by database mining and rapid expression screening
28. Genes differentially expressed in medulloblastoma and fetal brain
29. Large-scale serial analysis of gene expression reveals genes differentially expressed in ovarian cancer
30. Serial analysis of gene expression identifies putative metastasis-associated transcripts in colon tumour cell lines
31. Growth and migration markers of rat C6 glioma cells identified by serial analysis of gene expression
32. Identifying markers for pancreatic cancer by gene expression analysis
33. PGP9.5 as a candidate tumor marker for non-small-cell lung cancer
34. The human transcriptome map: Clustering of highly expressed genes in chromosomal domains
35. Genes expressed in human tumor endothelium
36. Hormones and mammary carcinogenesis in mice, rats, and humans: A unifying hypothesis
37. The role of the androgen receptor in the development and progression of prostate cancer
38. Multimeric coactivator complexes for steroid/nuclear receptors
39. Strategies for transcriptional activation by steroid/nuclear receptors
40. Increasing the complexity of coactivation in nuclear receptor signaling
41. A novel androgen-regulated gene, PMEPA1, located on chromosome 20q13 exhibits high level expression in prostate
42. WISP-2 as a novel estrogen-responsive gene in human breast cancer cells
43. Effects of estrogen on global gene expression: Identification of novel targets of estrogen action
44. p53 mutations in human cancers
45. The p53 pathway
46. p53: Puzzle and paradigm
47. The p53 pathway and apoptosis
48. Regulation of p53 downstream genes
49. SAGE transcript profiles for p53-dependent growth regulation
50. A model for p53-induced apoptosis
51. 14-3-3 sigma is a p53-regulated inhibitor of G2/M progression
52. 14-3-3 sigma is required to prevent mitotic catastrophe after DNA damage
53. Identification and classification of p53-regulated genes
54. Lessons from hereditary colorectal cancer
55. The adenomatous polyposis coli (APC) tumor suppressor
56. Carcinogenesis: A balance between beta-catenin and APC
57. APC: The plot thickens
58. Activation of beta-catenin-Tcf signaling in colon cancer by mutations in beta-catenin or APC
59. Constitutive transcriptional activation by a beta-catenin-Tcf complex in APC-/- colon carcinoma
60. Identification of c-MYC as a target of the APC pathway
61. Expression of c-myc and other cell cycle-dependent genes in human colon neoplasia
62. Expression of the myc gene family in different stages of human colorectal cancer
63. PPARdelta is an APC-regulated target of nonsteroidal anti-inflammatory drugs
64. The Myc/Max/Mad Network and the transcriptional control of cell behavior
65. Identification of CDK4 as a target of c-MYC
66. The Pezcoller lecture: Cancer cell cycles revisited
67. p53-dependent repression of cdk4 synthesis in transforming growth factor-beta-induced Gl cell cycle arrest
68. Inhibition of p53-mediated growth arrest by overexpression of cyclin-dependent kinases
69. Enforced CDK4 expression in a hematopoietic cell line confers resistance to the Gl arrest induced by ionizing radiation
70. Coamplification of the CDK4 gene with MDM2 and GLI in human sarcomas
71. Altered expression of cyclin D1 and CDK4 genes in ovarian carcinomas
72. Overexpression of cyclin D1 and cdk4 in tumorigenesis of sporadic hepatoblastomas
73. Gene amplification and tumor progression
74. Cyclin D, CDK4 and p16 expression in colorectal cancer